This study is testing a device called RespirAct to see if it can safely and effectively help identify coronary artery disease (heart disease). Researchers want to find the right levels of certain gases (high PC02 and low P02) that can act as stressors for future heart disease assessments. You may be able to join if you are an adult aged 45 or older with no known heart disease. The study will measure your body's responses (physiological parameters) and any symptoms you might have over 3 hours. The current status of this study is unclear, and it plans to enroll 80 healthy volunteers.

Study design

This is an interventional study, meaning participants will receive a specific intervention. It aims to enroll 80 healthy adults.

What's involved

Participants will use the RespirAct device and have their physiological parameters and symptoms monitored for 3 hours. You must be able to lie flat for 30-40 minutes.

Compensation

Not stated in the trial record.

Follow-up

Your physiological parameters and symptom severity will be assessed at 3 hours after the intervention.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.